Skip to content

CorMedix CRMD Foreign operations

Foreign operations at other companies

TFX
TeleflexTFX
-66.6%-70.0pp
Medline, Inc.
 logo
Medline, Inc. MDLN

Other financials

Income statement

See full
Revenue$127.4M+226%
Gross profit$115.4M+207%
Operating income$63.7M+216%
Net income$38.6M+87.0%
EPS (diluted)$0.43+43.3%

Balance sheet

See full
Cash & equivalents$179.1M+170%
Total debt$4.3M+729%
Total equity$437.0M+280%
Total assets$815.6M+445%

Cash flow

See full
Operating cash flow$42.4M+115%
CapEx$729.0K+7,190%
Free cash flow$41.7M+111%

Valuation

See full
Market cap$605.65M-34.4%
P/E3.4×
P/S1.5×-9.6×

Profitability

See full
Gross margin91.9%-3.5pp
Operating margin48.4%
Net margin45.2%
FCF margin48.7%+38.8pp

Returns & leverage

See full
Return on equity65.6%
Debt / equity0.0×
Current ratio-1.2×

Where this comes from

Reported directly by CorMedix in its filing.

Tagged under the XBRL concept us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential.

The official record: CorMedix’s 10-K, filed March 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about CorMedix's foreign operations.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is CorMedix's foreign operations?
CorMedix (CRMD) reported foreign operations of 0% in Q4 2025.
How has CorMedix's foreign operations changed year-over-year?
CorMedix's foreign operations increased by 100.0% year-over-year, from -0.3% to 0%.
What does foreign operations mean?
Captures the financial impact of earnings generated in foreign jurisdictions on the company's overall effective tax rate. It accounts for differences between domestic and international tax rates, including potential tax treaties or foreign tax credits. This is vital for evaluating the tax implications of the company's global business footprint.